Portfolio company
Cellagenics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology firm develops technology to enhance therapeutic antibody and protein production in mammalian cell lines for biopharmaceutical manufacturers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
BioCeros
This company provides cell line development services for monoclonal antibody production to biotechnology firms, pharmaceutical companies and academic institutions.
Augment Biologics
This company develops a glycoengineering platform for designing therapeutic proteins with specific sugar patterns for pharmaceutical manufacturers and biotechnology research teams.
Cellevate
This company develops nanofiber cell culture microcarriers for biopharmaceutical manufacturers to enhance viral vaccine and gene therapy production yields.
ChemT Biotechnology
This company develops AI-designed small molecules to enhance biologics production and cell productivity for pharmaceutical and biotechnology manufacturers.
XPAMAC
XPAMAC develops mammalian cell lines for therapeutic protein production, serving biopharmaceutical companies and contract development and manufacturing organisations.
ProBioGen AG
This company provides cell line engineering, process development and manufacturing services for biopharmaceutical companies and vaccine developers.
Bitrobius Genetics
This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.
Constellate Proteomics
This company develops single-molecule protein analysis platforms for biopharmaceutical drug developers to monitor antibody quality and rank cell lines during production.
